Back

Myocardial viability assessment using SPECT and PET

29 August 2017 (11:22 - 11:45)
Organised by:
Congress Presentation Part of: Nuclear imaging: a primer for the cardiologist Nuclear cardiology ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Rob Beanlands

University of Ottawa Heart Institute, Ottawa (Canada)

3 More presentations in this session

Presentation thumbnail
Early risk stratification in suspected CAD: what are the roles of CT and SPECT?
Doctor D. Berman (Los Angeles, US)
Slides Video
Presentation thumbnail
Guiding revascularisation in ischaemia by nuclear imaging techniques
Professor O. Gaemperli (Zurich, CH)
Slides Video
Presentation thumbnail
Nuclear techniques as a "non-invasive biopsy" for infiltrative myocardial diseases
Doctor S. Dorbala (Boston, US)

Access the full session

Session thumbnail
Nuclear imaging: a primer for the cardiologist

The Event

Event poster

ESC Congress 2017

29 August 2017 11:22 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of myocardial viability: a comparative study between parametric [15o] water PET/CT imaging and speckle tracking echocardiography
11 December 2025
thumbnail
Congress Presentation
Myocardial perfusion findings evaluated by gated-SPECT in dyslipidemic very high-risk patients.
9 May 2021
thumbnail
Congress Presentation
SPECT clinical cases with the experts - discussion
12 December 2025
thumbnail
Congress Presentation
Regional cardiac uptake of 99-Tc-DPD is a novel powerful and independent prognostic marker in cardiac ATTR wild type amyloidosis.
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources